DeepIntent
Healthcare-focused DSP and marketing cloud for pharmaceutical advertising.
Available information varies by company and source.
Profile record updated:
Company facts
- Official name
- DeepIntent, Inc.
- Entity type
- COMPANY
- Founded
- 2016
- Headquarters
- 4 Bryant Park, 4th Floor New York, NY 10018
- Company size
- 201–500
- Market role
- AdTech Vendor
- Official website
- deepintent.com
What DeepIntent does
DeepIntent operates a vertical AdTech platform model centred on healthcare and pharmaceutical advertising. It creates value by combining compliant healthcare data, audience creation, programmatic media buying, marketplace supply access, and measurement into an integrated platform stack. This allows enterprise advertisers and agencies to run campaigns in regulated healthcare contexts with more relevant targeting and more sector-specific attribution than generalist ad platforms typically provide.
Category differentiation
DeepIntent is a healthcare advertising technology platform for pharmaceutical media buying and measurement, not a general consumer health app or a healthcare provider. It is also distinct from broad horizontal DSPs because its core differentiation is healthcare-specific data, compliance, and outcome measurement.
Strategic context
AI-supported assessment from the existing company research; distinguish interpretation from sourced facts.
DeepIntent is a private US healthcare advertising technology company focused on pharmaceutical marketing. Its core offering is a healthcare-specific demand-side platform used by pharma brands, healthcare marketers, and agencies to plan, activate, optimise, and measure programmatic campaigns across channels including CTV, display, audio, video, and DOOH. The company combines media buying with healthcare audience data, clean room capabilities, and outcome measurement linked to clinical and prescribing signals. The business generates revenue primarily from media spend flowing through its DSP, supplemented by software and data revenue from products such as Helix, Cortex, Outcomes, and workflow tools for audience building and orchestration. Its customers are business buyers rather than consumers, chiefly enterprise pharmaceutical companies, healthcare-focused agencies, media planners, and marketing operations teams that need HIPAA-conscious targeting, healthcare datasets, and campaign measurement aligned to pharmaceutical KPIs such as script lift.
Company news briefing
Briefing updated:
Following its majority-stake acquisition by Vitruvian Partners, DeepIntent has launched Cora, an AI-powered agentic advertising platform designed to streamline pharmaceutical marketing workflows via multi-agent execution and the Helix data application. Furthermore, the company has expanded its inventory marketplace through a partnership with Vistar Media to integrate digital out-of-home inventory for healthcare marketers.
Business model & monetisation
DeepIntent primarily monetises through a percentage take-rate or platform economics attached to programmatic media spend executed through its DSP. It also generates SaaS-style revenue from access to its healthcare marketing cloud, clean room, analytics, measurement, and workflow tools, plus premium data and audience access. Commercial arrangements likely include enterprise contracts, platform access fees, minimum spend commitments, bundled data-and-media packages, and premium inventory marketplace fees.
- Programmatic media spend through DSP
- Percentage take-rate on media spend
- Healthcare marketing cloud and clean room access
- SaaS / software subscription
- Measurement and analytics products
- SaaS / software subscription
- Audience and data access
- Licensing or packaged platform fees
- Premium inventory marketplace access
- Marketplace margin or packaged media fees
Products & capabilities
No products with linked sources are available in this view.
Programmatic stack & registry data
Registry entries and observed technical data do not establish certification, legal compliance or actual usage.
DeepIntent, Inc.
IAB vendor record: 541
- Cookies declared
- Yes
- Non-cookie access declared
- No
- Declared purpose IDs
- 1, 3, 4
- Declared feature IDs
- 1, 2, 3
- Declared special purpose IDs
- 1, 2
Products & market categories
Technology
Media Channel
Competitors & alternatives
- Doceree
Healthcare adtech platform for pharma, publishers and HCP targeting.
Side-by-side comparisons
Recent recorded signals
Dates refer to the source publication. Older entries are historical context, not evidence of a new event.
DeepIntent launches agentic ad platform Cora for pharma marketing
Agentic Advertising · Recorded impact score: 4/5
DeepIntent, a healthcare-focused adtech firm, has launched Cora, an AI-powered agentic advertising platform designed for pharmaceutical marketers. The platform uses multiple AI agents to handle campaign planning, audience strategy, and media execution, including linear TV via a VideoAmp integration. Cora aims to speed up marketing workflows, with beta tests showing a 50% reduction in planning cycles and over 95% of clients reporting faster processes. This launch follows DeepIntent's majority stake sale to Vitruvian Partners, which provided $637 million to develop AI tools. The company targets the growing complexity of pharma marketing, especially for niche drugs targeting small patient populations. Cora is also powered by Helix, a data application providing aggregated healthcare data, including payer signals and drug coverage insights.
- DeepIntent launched Cora, an agentic ad platform for pharma marketing.
- Cora uses AI agents for campaign planning, audience targeting, and execution.
DeepIntent Expands Inventory Marketplace with Vistar Media Partnership, Bringing Premium Digital Out-of-Home Inventory to Healthcare Marketers
Recorded impact score: 4/5
DeepIntent Expands Inventory Marketplace with Vistar Media Partnership, Bringing Premium Digital Out-of-Home Inventory to Healthcare Marketers
Explore company relationships
Questions about DeepIntent
What is DeepIntent?
DeepIntent is a healthcare-focused advertising technology company that provides a DSP, data tools, and measurement products for pharmaceutical marketing.
Who uses DeepIntent?
Its primary users are pharmaceutical brands, healthcare marketers, media agencies, programmatic teams, and pharma marketing operations teams.
How does DeepIntent make money?
It makes money mainly from media spend flowing through its DSP, alongside software, data, and analytics fees for its broader healthcare marketing platform.
Sources & coverage
This profile uses public, official and technically observable information. Missing information does not prove that a product or relationship does not exist. The list below does not imply that every profile statement has been verified.
20 publicly documented primary sources and citations linked across the market graph.
Continue your research on DeepIntent
Explorer includes additional company details, a Watchlist for up to 25 companies and your personal Strategic Intelligence Agent. It monitors your market daily and delivers tailored briefings with clear strategic context whenever relevant news occurs.
Free, with no time limit.